Health insurer stocks take a hit as Medicare Advantage rates fall short of expectations

On Tuesday, shares of U.S. health insurers took a hit after the Biden administration did not increase payments for private Medicare plans as much as expected. This led to a decline in value for companies such as CVS Health, UnitedHealth Group, Elevance Health, Centene, and Humana.

The decision by the Centers for Medicare and Medicaid Services on Monday to raise government payments to Medicare Advantage plans by just 3.7% year over year, which is a 0.16% decline after stripping out certain assumptions, has added pressure on insurers already facing high medical costs and challenges following a cyberattack on UnitedHealth Group’s tech unit. The Medicare Advantage business has traditionally been a source of growth and profits for the insurance industry.

Medicare Advantage is a privately administered health insurance plan that works in conjunction with Medicare. More than half of Medicare beneficiaries are enrolled in these plans due to lower monthly premiums and added benefits not covered by traditional Medicare. The rate set by the federal agency determines how much insurers can charge for premiums, plan benefits, and ultimately, their profits. The current rate remains unchanged from an earlier proposal in January, which is not typical as the agency usually increases the rate after the initial proposal.

By Riley Johnson

As a content writer at, I dive into the depths of information to craft compelling stories that captivate and inform readers. With a keen eye for detail and a passion for storytelling, I strive to create engaging content that resonates with our audience. Whether it's breaking news, in-depth features, or thought-provoking opinion pieces, I am dedicated to delivering high-quality, informative content that keeps readers coming back for more. My goal is to bring a fresh perspective to every article I write and to make a meaningful impact through the power of words.

Leave a Reply